Intel (NASDAQ:INTC) is planning to apply Big Data into medicine. Recently, Intel and the Michael J. Fox Foundation have joined hands to pair smartwatches with Intel's analytics software for collecting data from sufferers of Parkinson's disease. Their ultimate goal is tracking the patients for monitoring disease progression, so that they can be effectively treated. We believe this new initiative will help Intel gain solid ground in the evolving mobile healthcare market.
Intel and the Michael J. Fox Foundation will jointly work for Parkinson's Research using data mining from wearable devices to detect patterns in disease progression. A study will be conducted, for which 25 Parkinson's patients who have initially enrolled will wear a smartwatch made by Pebble Technology. The smartwatch will detect sleep patterns, movement slowness and the disease's distinctive tremors. Intel's software platform will collect necessary data from the smartwatches that will allow researchers to examine the markers of Parkinson's disease, which is not possible with the naked eye. The Michael J. Fox Foundation has plans to enroll thousands more participants in the coming years, who will be compared to a control group.
In our original analysis, we said that Intel's future growth will be driven by the Internet of Things, better known as IoT. IoT and Big Data are closely related. IoT will help us doing basically everything online, which will lead to huge amount of data generation. The process of gathering, storing and analyzing that data is known as Big Data. The data generated by IoT in healthcare can drive new efficiencies, while advancing research and improving care. Intel's Big Data analytics platform is capable of integrating a number of software components, including Cloudera CDH - an open-source software platform that collects, stores and manages data. The company invested $740 million in software start-up, Cloudera. With its Big Data analytics platform, Intel will be able to track more than 300 observations per second from each patient. The platform, deployed on a cloud infrastructure optimized on Intel's processor architecture, will help scientists focus on research rather than the underlying computing technologies. For more information, read our original article.
Business relationship disclosure: The update has been written by a BB Research stock analyst. BB Research is not receiving compensation for it (other than from Seeking Alpha). BB Research has no business relationship with any company whose stock is mentioned in this article.
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.